Eisler Capital (UK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$171M Buy
192,894
+37,024
+24% +$33.3M 0.79% 28
2024
Q2
$141M Buy
155,870
+54,961
+54% +$44M 0.91% 23
2024
Q1
$78.5M Buy
100,909
+25,087
+33% +$17.9M 0.66% 34
2023
Q4
$44.2M Buy
75,822
+46,382
+158% +$27.1M 0.34% 69
2023
Q3
$15.8M Buy
29,440
+26,540
+915% +$13.7M 0.1% 169
2023
Q2
$1.36M Buy
+2,900
New +$1.22M 0.01% 289

Other funds holding LLY

Eisler Capital (UK)'s LLY Position: Q1 2024 in Review

Eisler Capital (UK) sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 1,238 shares — an estimated $881K sold.

Eisler Capital (UK) first reported a position in LLY in Q4 2023 and held it in 1 quarter. The position peaked at $722K in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Eisler Capital (UK) reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Eisler Capital (UK) sold 1,238 Eli Lilly shares in Q1 2024, an estimated $881K.
  • Eisler Capital (UK) first reported a position in Eli Lilly in Q4 2023 and held it in 1 quarter.
  • Eisler Capital (UK)'s Eli Lilly position peaked at $722K in Q4 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Eisler Capital (UK)'s 13F filing for Q1 2024, filed 14 May 2024.